Search

Your search keyword '"J, Turmo Martí"' showing total 2 results
Start Over Author "J, Turmo Martí"
2 results on '"J, Turmo Martí"'

1. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)]

Author

J, Cubells Riero, N, Pardo García, J, Turmo Martí, E, Vela Ferrer, R M, Badía Torroella, M A, González Rivero, J, Illa Sala, and M, Melo Valls

Subjects
Male, Lymphoma, Non-Hodgkin, Daunorubicin, Burkitt Lymphoma, Methotrexate, Vincristine, Child, Preschool, Antineoplastic Combined Chemotherapy Protocols, Humans, Prednisone, Female, Child, Cyclophosphamide, Neoplasm Staging
Abstract

The results obtained in the treatment of 37 children with non Hodgkin lymphoma belonging to GICOP between january 1982 and december 1986 are analysed. The therapy depend on the anatomopathology following the working formulation; LSALL2 protocol is used in lymphoblastic lymphoma, Burkitt-82 in undifferentiated Burkitt lymphoma and COMP in the remaining complete remission was archived in 94.6%. Murphy's classification is used. Disease free survival is 81% at 30 months. The actuarial survival is 0.81 for LL and 0.84 for BK at 48 months. The results obtained in the treatment of Burkitt's lymphoma with Burkitt-82 protocol and specially the absence of CNS infiltration are remarkable.

Published
1988

2. [Non-Hodgkin's lymphomas in childhood. Evaluation of therapeutic results according to histopathologic criteria (Catalan Interhospital Group of Pediatric Oncology)].

Author

Cubells Riero J, Pardo García N, Turmo Martí J, Vela Ferrer E, Badía Torroella RM, González Rivero MA, Illa Sala J, and Melo Valls M

Subjects
Burkitt Lymphoma drug therapy, Burkitt Lymphoma mortality, Burkitt Lymphoma pathology, Child, Child, Preschool, Cyclophosphamide administration & dosage, Daunorubicin administration & dosage, Female, Humans, Lymphoma, Non-Hodgkin mortality, Lymphoma, Non-Hodgkin pathology, Male, Methotrexate administration & dosage, Neoplasm Staging, Prednisone administration & dosage, Vincristine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lymphoma, Non-Hodgkin drug therapy
Abstract

The results obtained in the treatment of 37 children with non Hodgkin lymphoma belonging to GICOP between january 1982 and december 1986 are analysed. The therapy depend on the anatomopathology following the working formulation; LSALL2 protocol is used in lymphoblastic lymphoma, Burkitt-82 in undifferentiated Burkitt lymphoma and COMP in the remaining complete remission was archived in 94.6%. Murphy's classification is used. Disease free survival is 81% at 30 months. The actuarial survival is 0.81 for LL and 0.84 for BK at 48 months. The results obtained in the treatment of Burkitt's lymphoma with Burkitt-82 protocol and specially the absence of CNS infiltration are remarkable.

Published
1988

Catalog

Books, media, physical & digital resources
See catalog results